Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$2.14 - $3.4 $772,236 - $1.23 Million
-360,858 Reduced 94.76%
19,949 $43,000
Q4 2022

Feb 09, 2023

SELL
$2.03 - $2.42 $224,292 - $267,383
-110,489 Reduced 22.49%
380,807 $921,000
Q3 2022

Nov 09, 2022

BUY
$1.67 - $2.94 $739,105 - $1.3 Million
442,578 Added 908.45%
491,296 $1.15 Million
Q2 2022

Aug 11, 2022

BUY
$1.19 - $1.65 $57,974 - $80,384
48,718 New
48,718 $76,000
Q1 2022

May 12, 2022

SELL
$0.99 - $1.6 $105,101 - $169,860
-106,163 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$1.22 - $1.72 $28,859 - $40,686
-23,655 Reduced 18.22%
106,163 $130,000
Q3 2021

Nov 12, 2021

SELL
$1.2 - $1.5 $65,811 - $82,264
-54,843 Reduced 29.7%
129,818 $178,000
Q2 2021

Aug 10, 2021

BUY
$1.25 - $1.83 $230,826 - $337,929
184,661 New
184,661 $260,000
Q2 2020

Aug 13, 2020

SELL
$1.05 - $2.18 $85,108 - $176,702
-81,056 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$0.89 - $1.49 $108,730 - $182,031
-122,169 Reduced 60.12%
81,056 $96,000
Q4 2019

Feb 10, 2020

BUY
$1.27 - $1.54 $974 - $1,181
767 Added 0.38%
203,225 $276,000
Q3 2019

Nov 12, 2019

SELL
$1.15 - $1.59 $32,093 - $44,372
-27,907 Reduced 12.11%
202,458 $269,000
Q2 2019

Aug 09, 2019

SELL
$1.37 - $2.02 $26,034 - $38,386
-19,003 Reduced 7.62%
230,365 $325,000
Q1 2019

May 13, 2019

BUY
$1.01 - $1.83 $32,189 - $58,323
31,871 Added 14.65%
249,368 $414,000
Q4 2018

Feb 06, 2019

BUY
$0.98 - $1.85 $213,147 - $402,369
217,497 New
217,497 $218,000
Q3 2018

Nov 08, 2018

SELL
$1.76 - $6.38 $214,341 - $776,988
-121,785 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$3.29 - $4.82 $400,672 - $587,003
121,785 New
121,785 $418,000
Q1 2018

May 11, 2018

SELL
$1.81 - $5.98 $618,772 - $2.04 Million
-341,863 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$1.8 - $2.32 $145,323 - $187,305
80,735 Added 30.92%
341,863 $615,000
Q3 2017

Nov 15, 2017

SELL
$1.99 - $2.65 $87,130 - $116,027
-43,784 Reduced 14.36%
261,128 $569,000
Q2 2017

Aug 14, 2017

BUY
N/A
304,912
304,912 $845,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.1B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.